(Q35190615)

7 August 2017

Oxcarbazepine: a review of its use in children with epilepsy (English)

1 reference

7 August 2017

Lynne Bang

1

1 reference

7 August 2017

Karen Goa

series ordinal

2

1 reference

7 August 2017

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

5

1 reference

7 August 2017

8

1 reference

7 August 2017

557-573

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200305080-00006

7 August 2017

0 references

cites work

First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metabolite

1 reference

12 December 2020

Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers

1 reference

12 December 2020

Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine

1 reference

12 December 2020

Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy

1 reference

12 December 2020

Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight

1 reference

12 December 2020

When to start and stop anticonvulsant therapy in children

1 reference

12 December 2020

Oxcarbazepine in the treatment of early childhood epilepsy

1 reference

12 December 2020

Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine

1 reference

12 December 2020

Oxcarbazepine does not affect the anticoagulant activity of warfarin

1 reference

12 December 2020

Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy

1 reference

12 December 2020

Clinical pharmacology and pharmacokinetics of oxcarbazepine

1 reference

12 December 2020

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetic interactions of the new antiepileptic drugs

1 reference

12 December 2020

The distribution of 10-hydroxy carbazepine in blood compartments

1 reference

12 December 2020

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

12 December 2020

Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability

1 reference

12 December 2020

The clinical pharmacokinetics of the new antiepileptic drugs

1 reference

12 December 2020

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid

1 reference

12 December 2020

Oxcarbazepine does not interact with cimetidine in healthy volunteers

1 reference

12 December 2020

Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients

1 reference

12 December 2020

Newer therapies in the drug treatment of epilepsy

1 reference

12 December 2020

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

1 reference

12 December 2020

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

1 reference

12 December 2020

Hyponatremia induced by oxcarbazepine in children

1 reference

12 December 2020

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders

1 reference

12 December 2020

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission

1 reference

12 December 2020

Oxcarbazepine, an antiepileptic agent

1 reference

12 December 2020

Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis

1 reference

12 December 2020

Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects

1 reference

12 December 2020

Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy

1 reference

12 December 2020

Use of new antiepileptic drugs in the treatment of childhood epilepsy

1 reference

12 December 2020

Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment

1 reference

12 December 2020

The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.

1 reference

12 December 2020

Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view

1 reference

12 December 2020

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

12 December 2020

Overview of childhood epilepsy and epileptic syndromes and advances in therapy

1 reference

12 December 2020

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

1 reference

12 December 2020

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients

1 reference

12 December 2020

Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities.

1 reference

12 December 2020

Oxcarbazepine: an update of its efficacy in the management of epilepsy

1 reference

12 December 2020

Oxcarbazepine and hyponatremia

1 reference

12 December 2020

Oxcarbazepine: current status and clinical applications

1 reference

12 December 2020

New antiepileptic drugs in children: present and future

1 reference

12 December 2020

Oxcarbazepine (GP 47 680) in the treatment of intractable seizures

1 reference

12 December 2020

Quality of life in newly-debuted epilepsy. An empirical study.

1 reference

12 December 2020

Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study

1 reference

12 December 2020

Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

1 reference

12 December 2020

The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.

1 reference

12 December 2020

Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

1 reference

12 December 2020

Carbamazepine-induced skin rash in children with epilepsy

1 reference

12 December 2020

Absence of interaction between oxcarbazepine and erythromycin

1 reference

12 December 2020

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents

1 reference

12 December 2020

10.2165/00148581-200305080-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

1030890168

0 references

Fatcat ID

release_qrxmrx4wtfff5fk7zqy6nzv4tm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qrxmrx4wtfff5fk7zqy6nzv4tm

24 November 2022

mapped directly with Wikidata item

1 reference